Assembly Biosciences Inc Capital Reinvestment Ratio

Latest as of December 2025: 0.00x

Assembly Biosciences Inc capital reinvestment ratio. Assembly Biosciences Inc (ASMB) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($14.24 Million) in capital expenditures ($24.00K). Check ASMB cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$14.24 Million
USD

Capital Expenditures

$24.00K
USD

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Assembly Biosciences Inc (2017–2023)

Capital reinvestment ratio of Assembly Biosciences Inc from 2017 to 2023. This chart tracks Assembly Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore how fast is Assembly Biosciences Inc growing its equity to track the company's year-over-year net asset growth rate.

Assembly Biosciences Inc Capital Reinvestment Ratio by Year (2017–2023)

Assembly Biosciences Inc capital reinvestment ratio by year from 2017 to 2023. For the full cash flow conversion analysis, see ASMB cash flow metrics.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2023 0.01x $22.74 Million $255.00K ▼ -97.6%
2017 0.46x $1.86 Million $864.56K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow